Effective translation of cancer immunotherapy from bench to bedside can only occur through innovative research and collaboration. Therefore, we aim to create a centralized information platform (Virtual ImmunoTherapy Connection, VITC) comprising of clinical and preclinical samples with a focus on immunotherapy. This platform will be the first in the U.S. to efficiently consolidate immunotherapy resources across institutions into a searchable, interactive scientific network. Investigators will only need to deposit information about the samples they want to offer for collaboration, allowing other researchers to view this information and directly contact the investigator through the website. We strongly believe ‘that it is through collaboration that we shall find a cure’.